ARX vs PFE · rev $912.9M vs P/E 20, rev $15.03B
Accelerant Holdings (ARX) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Accelerant Holdings (ARX) is a insurance brokers company listed on NYSE.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported ARX revenue for 2025-12-31 was $912.9M. Net income was -$1.35B. Revenue was up 51.5% from 2024-12-31 to 2025-12-31. ARX currently screens at market cap $2.84B.
Latest reported PFE revenue for 2026-06-28 was $15.03B. Net income was -$248.0M. Revenue was up 4.0% from 2026-03-29 to 2026-06-28. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
ARX currently screens at market cap $2.84B. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the ARX and PFE stock pages for the full models.
Not investment advice.